ALKERMES | 매출원가



Cost Of Sales 변화 날짜
AbbVie USD 4.4B 184M 2024-12
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
ALKERMES USD 62.12M 984K 2024-12
Amgen USD 3.11B 198M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
J&J USD 7.3B 189M 2025-03
Malin Corporation EUR 15.4M 0 2020-12
Merck USD 3.71B 181M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Otsuka Holdings JPY 177.69B 11.16B 2024-12
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



ALKERMES 매출원가 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2025.